Questions: Neurobiological Mechanisms of Addiction

Question 1

A person who has been abstinent from heroin for 8 months walks past a street corner associated with past drug use and experiences intense craving before consciously thinking about drugs. Which neurobiological mechanism best explains this?

• A. Conscious deliberation: the person decided to seek drugs upon recognizing the location
• B. Cue-triggered dopamine sensitization: the cue automatically activates incentive salience circuitry before conscious deliberation begins
• C. Physical withdrawal: residual opioid dependence causes craving whenever the drug is absent
• D. Strengthened prefrontal control: the PFC is generating a plan to obtain the drug

Answer: (B)

This is the incentive salience model in action. Drug-associated cues trigger a sensitized dopamine response in the reward system that precedes conscious thought — the person doesn't choose to crave, the circuit fires first. Option A reverses the causal order; Option C confuses craving with physical withdrawal (which would have resolved months ago); Option D inverts the PFC story — addiction weakens, not strengthens, prefrontal control.

Question 2

What best distinguishes 'motivational tolerance' in chronic addiction from ordinary drug tolerance?

• A. Motivational tolerance means the person needs more drug to feel the same high; ordinary tolerance means the drug stops working entirely
• B. Motivational tolerance involves simultaneously losing sensitivity to natural rewards and gaining heightened reactivity to drug cues; ordinary tolerance is simply reduced drug effect requiring higher doses
• C. Motivational tolerance occurs only in the peripheral nervous system, while ordinary tolerance is central
• D. Motivational tolerance is reversible within days of abstinence; ordinary tolerance persists indefinitely

Answer: (B)

Motivational tolerance is not just 'the drug works less well.' It is a dual shift: natural rewards (food, sex, social connection) produce less dopamine release, while drug cues trigger sensitized craving. The person becomes less motivated toward life's ordinary rewards and more reflexively driven toward drug-related stimuli. Ordinary tolerance (needing more drug for the same effect) is a component of addiction, but it does not capture this reorganization of motivational priorities.

Question 3

The prefrontal cortex in someone with chronic addiction shows reduced gray matter volume and weakened inhibitory control, and these changes can persist for years after the person stops using drugs.

• T. True
• F. False

Answer: True

This is well-established. Chronic drug use causes lasting structural and functional changes to the PFC — the very region responsible for impulse control, long-term planning, and overriding limbic signals. The PFC takes years to recover, which is why even motivated, abstinent individuals have difficulty resisting powerful cravings from drug cues. This explains the clinical importance of behavioral therapies that specifically rebuild executive function.

Question 4

Addiction is primarily maintained by the desire to re-experience the intense pleasure of the drug high — once the euphoric effect diminishes through tolerance, the motivation to use should also diminish.

• T. True
• F. False

Answer: False

This is the most common misconception about addiction. The incentive salience model shows that tolerance to the drug's euphoric effect and sensitization to drug cues occur simultaneously and independently. As pleasure from the high decreases, cue-triggered craving actually intensifies. The system that drives compulsive drug-seeking is the motivational/wanting circuit, not the hedonic/liking circuit. Addicted individuals often report that they no longer enjoy the drug much but feel compelled to use — a pattern that directly contradicts a pleasure-maintenance model.

Question 5

Why does encountering a stress event or even a small priming dose of a drug trigger full relapse in someone who has been abstinent for months?

Model answer: Because the neuroadaptations that organized the brain around drug-seeking persist long after abstinence. The PFC, which provides inhibitory control, recovers slowly. The amygdala and anterior insula remain hyperreactive to cues and stress. The striatal habit circuitry retains the drug-seeking behavioral pattern. A stressor overwhelms weakened prefrontal control; a small dose triggers the sensitized reward system and reinstates the full drug-associated state. The brain's circuits are still structurally organized around drug-seeking even when the person has consciously committed to abstinence.

Relapse vulnerability is not a character flaw — it reflects biology. The three persistent neuroadaptations (weakened PFC, sensitized limbic system, entrenched striatal habits) create a brain that is still 'set up' for drug-seeking months or years after the last use. This is why effective treatment must simultaneously address all three levels: rebuilding executive function, reducing cue reactivity, and establishing competing behavioral routines.